TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Bird Construction ( (TSE:BDT) ) is now available.
Bird Construction Inc. has entered into a Development Phase Agreement with Infrastructure Ontario and William Osler Health System for the Peel Memorial Hospital Phase 2 Redevelopment project. This agreement marks Bird’s role as the Development Partner, where it will collaborate on the project’s design, schedule, pricing, and risk management. The project underscores Bird’s expertise in healthcare infrastructure and its commitment to delivering high-performing institutional projects, reinforcing its leadership in significant national sectors.
The most recent analyst rating on (TSE:BDT) stock is a Buy with a C$33.00 price target. To see the full list of analyst forecasts on Bird Construction stock, see the TSE:BDT Stock Forecast page.
Spark’s Take on TSE:BDT Stock
According to Spark, TipRanks’ AI Analyst, TSE:BDT is a Outperform.
Bird Construction’s strong financial performance, positive technical indicators, and strategic focus highlighted in the earnings call contribute to a solid overall score. While recent revenue declines and project delays pose challenges, the company’s robust backlog and improved margins provide a positive outlook.
To see Spark’s full report on TSE:BDT stock, click here.
More about Bird Construction
Bird Construction Inc. is a leading Canadian construction and maintenance company that operates nationwide. It offers a comprehensive range of construction services, focusing on industrial, buildings, and infrastructure markets. With over a century of experience, Bird is committed to safety and delivering long-term value for stakeholders.
Average Trading Volume: 276,822
Technical Sentiment Signal: Buy
Current Market Cap: C$1.69B
See more data about BDT stock on TipRanks’ Stock Analysis page.

